Phosphagenics already have the inside running here with their TPM-enhanced topical cream, which has been released in India as Vovaren (Novartis) and Instanac (Themis) gel. IMO Novartis will evaluate the take-up and effectiveness of the Vovaren product before introducing it into their Voltaren markets worldwide.
That's not to exclude the adoption of a next-gen OBJ-powered patch for strong joint/muscle pain indications.
gsk & novartis, page-4
Add WFL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| WFL (ASX) Chart |
Day chart unavailable